Peritoneal Metastasis of Gastric and Colorectal Cancer

1

Review clinical trials related to Peritoneal Metastasis of Gastric and Colorectal Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer

There have been initial explorations on the treatment of peritoneal metastasis of gastric and colorectal cancer both at home and abroad. However, the comprehensive treatment plan of "LDRT + NIPEC + immunotherapy + systemic therapy" has not been reported either domestically or internationally. This study will explore the safety and efficacy of total abdominal low-dose radiotherapy followed by NIPEC and PD-1 treatment for peritoneal metastasis of gastric and colorectal cancer. 9-18 participants will be enrolled in this study. All will take part at Daping Hospital, Army Medical University.

Participants needed: 9
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityUpdated: Apr 27, 2026Locations: 2
Eligibility criteria

Age between18 and 75 years old. [+6]

Presence of distant metastasis other than peritoneal metastasis (ovarian metasta... [+9]